Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays)

被引:46
作者
Raffa, RB
Codd, EE
机构
[1] Drug Discovery, R.W. Johnson Pharmaceutical Res. I., Spring House
[2] R-327, R.W. Johnson Pharmaceutical Res. I., Spring House, PA 19477-0776, Welsh and McKean Rds.
关键词
acetaminophen; paracetamol; analgesia; 5-HT receptors; receptor assays; uptake sites;
D O I
10.1016/0024-3205(96)00273-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The mechanism of analgesic action of acetaminophen (paracetamol) remains unknown. However, a central component distinct from that of the NSAIDs (non-steroidal antiinflammatory drugs) seems likely. A recent report (NeuroReport 6:1546-1548, 1995) suggests the involvement of 5-HT3 receptors. In the present study, we measured the affinity of acetaminophen at 5-HT3, as well as 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2, 5-HT2C, 5-HT4, 5-HT6, 5-HT7 and eleven other receptor sites and at serotonin and norepinephrine reuptake sites. At 10 mu M, acetaminophen inhibited less than 10% specific radioligand binding at any site. These findings: (i) suggest that acetaminophen's effect on serotonergic pathways is indirect, and (ii) circumscribe acetaminophen's possible central analgesic mechanism(s).
引用
收藏
页码:PL37 / PL40
页数:4
相关论文
共 28 条
[1]   THE BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTOR AFFINITY OF ATENOLOL AND METOPROLOL - A RECEPTOR-BINDING STUDY PERFORMED WITH DIFFERENT RADIOLIGANDS IN TISSUES FROM THE RAT, THE GUINEA-PIG AND MAN [J].
ABRAHAMSSON, T ;
EK, B ;
NERME, V .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (02) :203-208
[2]   ACETAMINOPHEN [J].
AMEER, B ;
GREENBLATT, DJ .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (02) :202-209
[3]   CENTRAL ANALGESIC EFFECTS OF ASPIRIN-LIKE DRUGS [J].
BANNWARTH, B ;
DEMOTESMAINARD, F ;
SCHAEVERBEKE, T ;
LABAT, L ;
DEHAIS, J .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (01) :1-7
[4]   OPIATE RECEPTOR-BINDING AFFECTED DIFFERENTIALLY BY OPIATES AND OPIOID PEPTIDES [J].
CHILDERS, SR ;
CREESE, I ;
SNOWMAN, AM ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 55 (01) :11-18
[5]   CRITICAL FACTORS OF INTRACEREBRAL MICRODIALYSIS AS A TECHNIQUE TO DETERMINED THE PHARMACOKINETICS OF DRUGS IN RAT-BRAIN [J].
DELANGE, ECM ;
DANHOF, M ;
DEBOER, AG ;
BREIMER, DD .
BRAIN RESEARCH, 1994, 666 (01) :1-8
[6]   LABELING OF RAT-HEART MUSCARINIC RECEPTORS USING THE NEW M2 SELECTIVE ANTAGONIST [H-3] AF-DX 384 [J].
ENTZEROTH, M ;
MAYER, N .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1674-1676
[7]   CHARACTERIZATION OF CENTRAL NEUROPEPTIDE-Y RECEPTOR-BINDING SITES AND POSSIBLE INTERACTIONS WITH ALPHA-2-ADRENOCEPTORS [J].
GOLDSTEIN, M ;
KUSANO, N ;
ADLER, C ;
MELLER, E .
PROGRESS IN BRAIN RESEARCH, 1986, 68 :331-335
[8]   BINDING CHARACTERISTICS OF PRAZOSIN-H-3 TO RAT-BRAIN ALPHA-ADRENERGIC RECEPTORS [J].
GREENGRASS, P ;
BREMNER, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 55 (03) :323-326
[9]   DEVELOPMENT OF A RADIOLIGAND BINDING ASSAY FOR 5-HT(4)-RECEPTORS IN GUINEA-PIG AND RAT-BRAIN [J].
GROSSMAN, CJ ;
KILPATRICK, GJ ;
BUNCE, KT .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (03) :618-624
[10]   [H-3]8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN BINDING TO PRESYNAPTIC AND POSTSYNAPTIC 5-HYDROXYTRYPTAMINE SITES IN VARIOUS REGIONS OF THE RAT-BRAIN [J].
HALL, MD ;
ELMESTIKAWY, S ;
EMERIT, MB ;
PICHAT, L ;
HAMON, M ;
GOZLAN, H .
JOURNAL OF NEUROCHEMISTRY, 1985, 44 (06) :1685-1696